Dynamic spectrum of ectopic lymphoid B cell activation and hypermutation in the RA synovium characterized by NR4A nuclear receptor expression.
B cells
CP: Immunology
ectopic lymphoid structure
rheumatoid arthritis
single-cell RNA-seq
synovial tissue
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
03 05 2022
03 05 2022
Historique:
received:
13
09
2021
revised:
13
02
2022
accepted:
11
04
2022
entrez:
4
5
2022
pubmed:
5
5
2022
medline:
7
5
2022
Statut:
ppublish
Résumé
Ectopic lymphoid structures (ELS) can develop in rheumatoid arthritis (RA) synovial tissue, but the precise pathways of B cell activation and selection are not well understood. Here, we identify a synovial B cell population characterized by co-expression of a family of orphan nuclear receptors (NR4A1-3), which is highly enriched in RA synovial tissue. A transcriptomic profile of NR4A synovial B cells significantly overlaps with germinal center light zone B cells and an accrual of somatic hypermutation that correlates with loss of naive B cell state. NR4A B cells co-express lymphotoxins α and β and IL-6, supporting functions in ELS promotion. Expanded and shared clones between synovial NR4A B cells and plasma cells and the rapid upregulation with BCR stimulation point to in situ differentiation. Together, we identify a dynamic progression of B cell activation in RA synovial ELS, with NR4A transcription factors having an important role in local adaptive immune responses.
Identifiants
pubmed: 35508128
pii: S2211-1247(22)00530-7
doi: 10.1016/j.celrep.2022.110766
pmc: PMC9234997
mid: NIHMS1808031
pii:
doi:
Substances chimiques
Receptors, Cytoplasmic and Nuclear
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110766Subventions
Organisme : NIAMS NIH HHS
ID : UH2 AR067685
Pays : United States
Organisme : NIAMS NIH HHS
ID : R21 AR071670
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002001
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE027245
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067681
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067688
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067689
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067690
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067677
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067694
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI078907
Pays : United States
Organisme : Medical Research Council
ID : G0800648
Pays : United Kingdom
Organisme : NIAMS NIH HHS
ID : R01 AR078268
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067679
Pays : United States
Organisme : NIAMS NIH HHS
ID : UM2 AR067678
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR069655
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067676
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067691
Pays : United States
Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests S.R. is a paid consultant for Gilead, Pfizer, Rheos, and J&J, and is a founder of Mestag. D.E.O. is an inventor of two non-licensed patents; US 63/031,861 entitled “markers and Cellular Antecedents of Rheumatoid Arthritis Flares” and US 63/050,155 entitled “method and System for RNA Isolation from Self-Collected and Small Volume Samples.” S.G. receives research support from Novartis and is a consultant for UCB.
Références
Cell Mol Immunol. 2011 Jul;8(4):281-4
pubmed: 21217771
Ann Rheum Dis. 2019 Jun;78(6):761-772
pubmed: 30878974
Blood. 1997 Feb 15;89(4):1288-98
pubmed: 9028952
Methods Mol Biol. 2012;882:569-604
pubmed: 22665256
Arthritis Rheum. 2008 Nov;58(11):3377-87
pubmed: 18975336
Immunity. 2018 Apr 17;48(4):702-715.e4
pubmed: 29669250
J Immunol. 2015 Apr 1;194(7):2993-7
pubmed: 25725108
Nature. 2012 Sep 6;489(7414):160-4
pubmed: 22902503
Immunol Rev. 2010 Jan;233(1):267-85
pubmed: 20193005
Blood. 2012 Sep 13;120(11):2240-8
pubmed: 22740445
Nat Immunol. 2019 Feb;20(2):163-172
pubmed: 30643263
J Exp Med. 1998 Nov 2;188(9):1679-89
pubmed: 9802980
J Exp Med. 2020 Oct 5;217(10):
pubmed: 32603407
Immunity. 2017 Dec 19;47(6):1142-1153.e4
pubmed: 29262350
Nat Med. 2020 Aug;26(8):1295-1306
pubmed: 32601335
Nature. 2019 Mar;567(7749):530-534
pubmed: 30814732
Nat Immunol. 2019 Jul;20(7):928-942
pubmed: 31061532
Rheumatol Int. 2008 Aug;28(10):979-86
pubmed: 18379788
Arthritis Res Ther. 2018 Jul 11;20(1):139
pubmed: 29996944
Nat Immunol. 2020 Oct;21(10):1267-1279
pubmed: 32868928
J Immunol. 2007 Jul 1;179(1):13-9
pubmed: 17579014
J Exp Med. 2014 May 5;211(5):987-1000
pubmed: 24733829
Arthritis Rheum. 2011 Jan;63(1):63-72
pubmed: 20882667
J Leukoc Biol. 2018 Aug;104(2):333-341
pubmed: 29947426
Genes Immun. 2003 Jul;4(5):343-50
pubmed: 12847549
Immunity. 2002 Sep;17(3):239-50
pubmed: 12354378
J Immunol. 2019 May 15;202(10):2907-2923
pubmed: 30962292
Nature. 2009 Aug 27;460(7259):1122-6
pubmed: 19597478
Arthritis Rheumatol. 2016 Apr;68(4):805-16
pubmed: 26554541
J Clin Invest. 2012 May;122(5):1791-802
pubmed: 22505457
Clin Immunol. 2020 Mar;212:108360
pubmed: 32035179
Arthritis Rheumatol. 2018 Nov;70(11):1732-1744
pubmed: 29855173
J Immunol. 1988 Mar 1;140(5):1454-60
pubmed: 3126226
J Immunol. 2011 Nov 1;187(9):4621-8
pubmed: 21948984
J Clin Med. 2019 Aug 16;8(8):
pubmed: 31426398
J Exp Med. 2017 Nov 6;214(11):3435-3448
pubmed: 28939548
Cell Rep. 2019 Aug 27;28(9):2455-2470.e5
pubmed: 31461658
J Immunol. 2001 Aug 1;167(3):1313-24
pubmed: 11466348
N Engl J Med. 2020 Jul 16;383(3):218-228
pubmed: 32668112
J Immunol. 2001 Jul 15;167(2):1072-80
pubmed: 11441118
J Immunol. 2001 Oct 1;167(7):3610-8
pubmed: 11564773
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
PLoS Med. 2009 Jan 13;6(1):e1
pubmed: 19143467
Nat Rev Immunol. 2004 May;4(5):360-70
pubmed: 15122201
Cell Rep. 2020 Nov 3;33(5):108328
pubmed: 33147449
Nat Immunol. 2014 Feb;15(2):195-204
pubmed: 24336226
Am J Pathol. 2007 Nov;171(5):1549-62
pubmed: 17982129
J Immunol. 2017 Jan 15;198(2):657-668
pubmed: 27940659
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18517-18527
pubmed: 31455730
Semin Arthritis Rheum. 2019 Feb;48(4):597-602
pubmed: 30075990
Nature. 2019 Mar;567(7749):525-529
pubmed: 30814730
Nat Immunol. 2018 Sep;19(9):1013-1024
pubmed: 30104629
Ann Rheum Dis. 2016 Oct;75(10):1866-75
pubmed: 26659717
Immunity. 2018 Oct 16;49(4):725-739.e6
pubmed: 30314758
Sci Immunol. 2021 Feb 12;6(56):
pubmed: 33579751
Nat Commun. 2018 Dec 3;9(1):5127
pubmed: 30510188
J Immunol. 1993 Jun 1;150(11):4822-32
pubmed: 8388422
J Exp Med. 2011 Jan 17;208(1):125-34
pubmed: 21173107
J Immunol. 2009 Jun 15;182(12):7595-602
pubmed: 19494283
Nat Immunol. 2019 Jul;20(7):902-914
pubmed: 31209404
Nat Commun. 2020 May 22;11(1):2570
pubmed: 32444631
J Virol. 2010 Dec;84(23):12405-18
pubmed: 20861250
Front Immunol. 2020 May 06;11:736
pubmed: 32435242
Clin Exp Immunol. 1993 Sep;93(3):387-95
pubmed: 8370165
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601
Sci Transl Med. 2020 Nov 18;12(570):
pubmed: 33208502
J Exp Med. 2017 Nov 6;214(11):3207-3217
pubmed: 28899868
Semin Immunopathol. 2017 Jun;39(4):437-446
pubmed: 28451788
Arthritis Rheum. 1988 Aug;31(8):956-63
pubmed: 2457377
J Exp Med. 2002 Jul 1;196(1):65-75
pubmed: 12093871